Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

AuthID
P-00V-ZQG
24
Author(s)
Makker V.
·
Colombo N.
·
Herráez A.C.
·
Santin A.D.
·
Colomba E.
·
Fujiwara K.
·
Pignata S.
·
Baron-Hay S.
·
Ray-Coquard I.
·
[+3]·
[+1]·
Guerra E.M.
·
Sanli U.A.
·
McCormack M.M.
·
Smith A.D.
·
Keefe S.
·
Bird S.
·
Dutta L.
·
Orlowski R.J.
·
Lorusso D.
Document Type
Article
Year published
2022
Published
in New England Journal of Medicine, ISSN: 00284793
Volume: 386, Issue: 5, Pages: 437-448 (11)
Indexing
Publication Identifiers
Pubmed: 35045221
SCOPUS: 2-s2.0-85123770350
Source Identifiers
ISSN: 00284793
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Makker V.;   2 Colombo N.;   3 Herráez A.C.;
4 Santin A.D.;   5 Colomba E.;   6 Miller D.S. ;
7 Fujiwara K.;   8 Pignata S.;   9 Baron-Hay S.;
10 Ray-Coquard I.;   11 Shapira-Frommer R.;   12 Ushijima K.;
13 Sakata J.;   14 Yonemori K.;   15 Kim Y.M.;
16 Guerra E.M.;   17 Sanli U.A.;   18 McCormack M.M.;
19 Smith A.D.;   20 Keefe S.;   21 Bird S.;
22 Dutta L.;   23 Orlowski R.J.;   24 Lorusso D.;